Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

被引:3716
作者
Alpert, JS
Antman, E
Apple, F
Armstrong, PW
Bassand, JP
de Luna, AB
Beller, G
Breithardt, G
Chaitman, BR
Clemmensen, P
Falk, E
Fishbein, MC
Galvani, M
Garson, A
Grines, C
Hamm, C
Jaffe, A
Katus, H
Kjekshus, J
Klein, W
Klootwijk, P
Lenfant, C
Levy, D
Levy, RI
Luepker, R
Marcus, F
Näslund, U
Ohman, M
Pahlm, O
Poole-Wilson, P
Popp, R
Alto, P
Pyörälä, K
Ravkilde, J
Rehnquist, N
Roberts, W
Roberts, R
Roelandt, J
Rydén, L
Sans, S
Simoons, ML
Thygesen, K
Tunstall-Pedoe, H
Underwood, R
Uretsky, BF
Van de Werf, F
Voipio-Pulkki, LM
Wagner, G
Wallentin, L
Wijns, W
机构
关键词
D O I
10.1016/S0735-1097(00)00804-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Definition of MI. Criteria for acute, evolving or recent MI. Either one of the following criteria satisfies the diagnosis for an acute, evolving or recent MI: 1) Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one of the following: a) ischemic symptoms; b) development of pathologic Q waves on the ECG; c) ECG changes indicative of ischemia (ST segment elevation or depression); or d) coronary artery intervention (e.g., coronary angioplasty). 2) Pathologic findings of an acute MI. Criteria for established MI. Any one of the following criteria satisfies the diagnosis for established MI: 1) Development of new pathologic Q waves on serial ECGs. The patient may or may not remember previous symptoms. Biochemical markers of myocardial necrosis may have normalized, depending on the length of time that has passed since the infarct developed. 2) Pathologic findings of a healed or healing MI.
引用
收藏
页码:959 / 969
页数:11
相关论文
共 58 条
[1]   Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation [J].
Alexander, JH ;
Sparapani, RA ;
Mahaffey, KW ;
Deckers, JW ;
Newby, LK ;
Ohman, EM ;
Corbalán, R ;
Chierchia, SL ;
Boland, JB ;
Simoons, ML ;
Califf, RM ;
Topol, EJ ;
Harrington, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :347-353
[2]   EVALUATION OF A QRS SCORING SYSTEM FOR ESTIMATING MYOCARDIAL INFARCT SIZE .6. IDENTIFICATION OF SCREENING CRITERIA FOR NON-ACUTE MYOCARDIAL INFARCTS [J].
ANDERSON, WD ;
WAGNER, NB ;
LEE, KL ;
WHITE, RD ;
YUSCHAK, J ;
BEHAR, VS ;
SELVESTER, RH ;
IDEKER, RE ;
WAGNER, GS .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (10) :729-733
[3]  
[Anonymous], 1968, CARDIOVASCULAR SURVE
[4]   Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T [J].
Antman, EM ;
Grudzien, C ;
Mitchell, RN ;
Sacks, DB .
AMERICAN HEART JOURNAL, 1997, 133 (05) :596-598
[5]   Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes [J].
Antman, EM ;
Tanasijevic, MJ ;
Thompson, B ;
Schactman, M ;
McCabe, CH ;
Cannon, CP ;
Fischer, GA ;
Fung, AY ;
Thompson, C ;
Wybenga, D ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (18) :1342-1349
[6]   Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB [J].
Apple, FS .
CLINICA CHIMICA ACTA, 1999, 284 (02) :151-159
[7]  
Apple FS, 1997, CLIN CHEM, V43, P2047
[8]  
Apple FS, 1999, CLIN CHEM, V45, P18
[9]  
Bardales RH, 1996, AM J PATHOL, V149, P821
[10]   Assessment of myocardial viability [J].
Beller, GA .
CURRENT OPINION IN CARDIOLOGY, 1997, 12 (05) :459-467